Ces radiol. 2010, 64(3):192-197

One-day scintigraphic procedure combining 99mTc-MIBI/pertechnetate subtraction method with perchlorate discharge and double-phase 99mTc-MIBI scintigraphy with SPECT in patients with tertiary hyperparatyroidismOriginal article

Pavel Koranda1, Milan Halenka2, Jana Zahálková3, Zdena Kosatíková2, Miroslav Mysliveček1
1 Klinika nukleární medicíny LF UP a FN, Olomouc
2 III. interní klinika LF UP a FN, Olomouc
3 Hemodialyzační oddělení, Středomoravská nemocniční a.s., Nemocnice Šternberk

Aim: To evaluate the capability of one-day comprehensive scintigraphic procedure to detect a nodular hyperplasia (NH) of parathyroid glands in patients with tertiary hyperparathyroidism.

Methods: A group of 15 patients with tertiary hyperparathyroidism underwent a one-day scintigraphic procedure. 21 hyperplastic parathyroid glands (volumes 0.1-2.2 ml, mean value 0.7 ml, median 0.5 ml) were diagnosed in 13 patients using either ultrasonography (US) with fine needle aspiration biopsy or surgery. The comprehensive scintigraphic procedure was acquired during 3 hours and consisted of 99mTc-MIBI/pertechnetate subtraction method with perchlorate discharge and double-phase 99mTc-MIBI scintigraphy with SPECT.

Results: Subtraction scintigraphy was not evaluated in 2 patients due to absent pertechnetate uptake. 16 NH of parathyroid glands were detected on scintigraphs (12 NH using the subtraction method, 13 NH by the double-phase MIBI scintigraphy and 9 NH by both methods). 2 NH diagnosed using the scintigraphy did not show any US correlation. The comprehensive scintigraphic procedure was negative in 5 cases (volumes 0.2, 0.4, 0.4, 0.5 and 0.5 ml).

Conclusion: Our comprehensive one-day scintigraphic procedure (subtraction method with perchlorate discharge and double-phase MIBI scintigraphy with SPECT) has been able to detect NH of parathyroid glands in the majority of patients with tertiary hyperparathyroidism regardless of the small size of lesions and incidental ectopy. The subtraction procedure and double-phase MIBI scintigraphy are complementary methods, and the sensitivity of NH detection is increased using simultaneous combination of both of them. Similar complementarity exists also between scintigraphy and ultrasonography.

Keywords: hyperparathyroidism, radionuclide imaging, technetium Tc 99m sestamibi, sodium pertechnetate Tc 99m

Accepted: June 15, 2010; Published: September 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koranda P, Halenka M, Zahálková J, Kosatíková Z, Mysliveček M. One-day scintigraphic procedure combining 99mTc-MIBI/pertechnetate subtraction method with perchlorate discharge and double-phase 99mTc-MIBI scintigraphy with SPECT in patients with tertiary hyperparatyroidism. Ces radiol. 2010;64(3):192-197.
Download citation

References

  1. Elgazzar A. (ed.) The pathophysiologic basis of nuclear medicine. Berlin: Springer 2001; 141-146.
  2. Pelizzo MR, Pagetta C, Piotto A, et al. Surgical treatment of primary hyperparathyroidism: from bilateral neck exploration to minimally invasive surgery. Minerva Endocrinol 2008; 33: 85-93.
  3. Smith N, Magnuson JS, Vidrine DM, Kulbersh B, Peters GE. Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies. Arch Otolaryngol Head Neck Surg 2009; 135: 1108-1111. Go to original source... Go to PubMed...
  4. Vulpio C, Bossola M, De Gaetano A, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck. 2010 Jan 20 [Epub ahead of print]. Go to original source... Go to PubMed...
  5. Pham TH, Sterioff S, Mullan BP, et al. Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism. World J Surg 2006; 30: 327-332. Go to original source... Go to PubMed...
  6. Lai EC, Ching AS, Leong HT. Secondary and tertiary hyperparathyroidism: role of preoperative localization. ANZ J Surg 2007; 77: 880-882. Go to original source... Go to PubMed...
  7. Périé S, Fessi H, Tassart M, et al. Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123I/technetium Tc99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 2005; 45: 344. Go to original source... Go to PubMed...
  8. Piga M, Bolasco P, Satta L, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37: 565-569.
  9. Loftus KA, Anderson S, Mulloy AL, Terris DJ. Value of sestamibi scans in tertiary hyperparathyroidism. Laryngoscope 2007; 117: 2135-2138. Go to original source... Go to PubMed...
  10. Fjeld JG, Rootvelt K. Parathyroid scintigraphy with 99mTc-labeled radiopharmaceutical immediately after thyroid scintigraphy with 99mTc-pertechnetate (abstrakt). In: Proceedings from 16th Annual Meeting: Radiation Protection and Nuclear Medicine. Oslo, Norway: Norvegian Society of Nuclear Medicine; 1996: 38.
  11. Hindié E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36: 1201-1216. Go to original source... Go to PubMed...
  12. Rubello D, Saladini G, Casara D, et al. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique. Clin Nucl Med 2000; 25: 527-531. Go to original source... Go to PubMed...
  13. Lyngby J. Use of perchlorate in parathyroid scintigraphy (a letter). J Nucl Med 1998; 39: 1306.
  14. Koranda P, Halenka M, Myslivecek M, Kaminek M. Localization of parathyroid enlargement: dual-tracer subtraction technique and double-phase 99mTc-MIBI scintigraphy are complementary procedures. Eur J Nucl Med Mol Imaging 2008; 35: 219-220. Go to original source... Go to PubMed...
  15. Chen CC, Holder LE, Scovili WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997; 38: 834-839.
  16. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005; 35(4): 266-276. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.